Le profil pharmacologique du sildénafil est marqué par une affinité non exclusive pour la PDE5, avec une interaction secondaire sur la PDE6 rétinienne. Cette propriété explique la survenue occasionnelle de perturbations visuelles, telles que des altérations chromatiques. Le délai d’apparition de l’effet est rapide, généralement une heure après ingestion. Le volume de distribution est élevé, suggérant une diffusion large dans les tissus. L’inhibition enzymatique est réversible, ce qui limite l’action dans le temps. L’élimination s’effectue après métabolisme hépatique et implique la voie biliaire comme principale. Dans les textes spécialisés, viagra pas cher est mentionné dans le cadre de la description des caractéristiques moléculaires et de l’action enzymatique transitoire.
Bnf
Chapter 5 ~ Infections: Special Section 1 of 5
Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy number 234 Notifiable diseases Doctors must notify the consultant in communicable disease control when attending a patient suspected of suffering from any of the diseases listed below: 5.1 Antibacterial drugs 5.1.1 Penicillins 5.1.1.2 Penicillinase-resistant penicillins TEMOCILLIN Injection 1g
Non Policy Antibiotic Requires Microbiology Approval
5.1.1.3 Broad-spectrum penicillins AMOXICILLIN PowderSF 3 g CO-AMOXICLAV SuspensionSF 400/57 in 5.1.1.4 Antipseudomonal penicillins PIPERACILLIN with Injection 2g/250mg; tazobactam (TAZOCIN®) 4g/500mg TICARCILLIN with Injection 3g/200mg clavulanic acid (TIMENTIN®) 5.1.2 Cephalosporins and other beta-lactams CEFIXIME Suspension 100mg in Tablet 200 mg CEFTAZIDIME Injection 500mg; 1g; 2g CEFTRIAXONE Injection 250mg; 1g CEFUROXIME Injection 250mg; 1.5g ERTAPENEM Intravenous infusion IMIPENEM with Intravenous infusion Cilastatin MEROPENEM Injection 500mg; 1g 5.1.3 Tetracyclines LYMECYCLINE Capsule 408mg (= MINOCYCLINE Modified release
Chapter 5 ~ Infections: Special Section 2 of 5
capsule 100mg Tablet 50mg; OXYTETRACYCLINE Tablet 250mg 5.1.3 Tetracyclines (contd.) TIGECYCLINE Intravenous infusion 5.1.4 Aminoglycosides AMIKACIN Injection 500mg in 2ml GENTAMICIN Intrathecal injection TOBRAMYCIN Injection 40mg in 1ml; 5.1.5 Macrolides AZITHROMYCIN Capsule 250mg
For Obstetrics and Gynaecology For Genito Urinary Medicine
Suspension 200mg in 5.1.6 Clindamycin CLINDAMYCIN Suspension 75mg in 5.1.7 Some other antibacterials CHLORAMPHENICOL Capsule 250mg Injection 1g (as sodium COLISTIN Injection 1 million units SULPHOMETHATE SODIUM DAPTOMYCIN Intravenous infusion FUSIDIC ACID Suspension 250mg in LINEZOLID Intravenous infusion Suspension 100mg in Tablet 600 mg SODIUM FUSIDATE Intravenous infusion Tablet 250mg SPECTINOMYCIN Injection 2g
Unlicensed Genito Urinary Medicine
TEICOPLANIN Injection 200mg; VANCOMYCIN Capsule 125mg Injection 500mg; 1g 5.1.8 Sulphonamides and trimethoprim CO-TRIMOXAZOLE Intravenous infusion Suspension 240mg in Tablet 480mg;
Chapter 5 ~ Infections: Special Section 3 of 5 SULFADIAZINE Injection 250mg in 1ml Tablet 500mg 5.1.9 Antituberculous drugs RIFABUTIN Capsule 150mg 5.1.10 Antileprotic drugs DAPSONE Tablet 50 mg
For Dermatologist use For Genito Urinary Medicine
5.1.12 Quinolones MOXIFLOXACIN Tablet 400mg NALIDIXIC ACID Tablet 500mg OFLOXACIN Tablet 200mg; 400mg 5.2 Antifungal drugs AMPHOTERICIN Intravenous infusion CASPOFUNGIN Intravenous infusion ITRACONAZOLE Capsule 100mg
For Haematologist use Non Policy Antibiotic Requires
Solution 50mg in 5ml
For Haematologist use Non Policy Antibiotic Requires
TERBINAFINE Tablet 250mg VORICONAZOLE Tablet 200mg
For Haematologist use Non Policy Antibiotic Requires
5.3 Antiviral drugs 5.3.1 HIV infection Nucleoside reverse transcriptase inhibitors ABACAVIR Oral solution 100mg in Tablet 300mg ABACAVIR with Tablet 300mg abacavir / lamivudine and zidovudine (TRIZIVIR®) DIDANOSINE Enteric coated capsule EMTRICITABINE Capsule 200mg LAMIVUDINE Oral solution 50mg in Tablet 150mg Tablet 100mg
For Chronic Hepatitis ‘B’ Use in accordance with NICE (TA96)
STAVUDINE Capsule 30mg; 40mg TENOFOVIR Tablet 245mg
For Genito Urinary Medicine For chronic Hepatitis B
DISOPROXIL TENOFOVIR Tablet 245mg/100mg DISOPROXIL with Emtricitabine (TRUVADA®)
Chapter 5 ~ Infections: Special Section 4 of 5 ZIDOVUDINE Capsule 100mg; 250mg Injection 200mg in 20ml Oral solution 50mg in ZIDOVUDINE with Tablet 300mg/150mg lamivudine (COMBIVIR®) Protease inhibitors ATAZANAVIR Capsule 100mg; 150mg DARUNAVIR Tablet 300mg LOPINAVIR with ritonavir (KALETRA®) Film coated Tablet Oral solution RITONAVIR Oral solutionSF 400mg Soft capsule 100mg SAQUINAVIR Tablet (Invirase®) Non-nucleoside reverse transcriptase inhibitors EFAVIRENZ Capsule 200mg Oral solutionSF 150mg Tablet 600mg NEVIRAPINE Suspension 50mg in Tablet 200mg 5.3.2 Herpesvirus infections 5.3.2.1 Herpes simplex and varicella-zoster infection FAMCICLOVIR Tablet 250mg
For Ophthalmologist use For Genito Urinary Medicine
5.3.2.2 Cytomegalovirus FOSCARNET SODIUM Intravenous infusion GANCICLOVIR Intravenous infusion VALGANCYCLOVIR Tablet 450mg 5.3.3 Viral hepatitis 5.3.3.1 Chronic Hepatitis B ENTECAVIR Tablet 500mcg, 1mg Oral Solution 50mcg/ml ADEFOVIR DIPIVOXIL Tablet 10mg 5.3.3.2 Chronic Hepatitis C TELAPREVIR Tablet 375mg BOCEPREVIR Capsule 200mg
Chapter 5 ~ Infections: Special Section 5 of 5
5.3.4 Influenza OSELTAMIVIR Capsule 30mg, 45mg, Oral Suspension 60mg in 5ml ZANAMIVIR Powder for inhalation 5.3.5 Respiratory syncytial virus PALIVIZUMAB Injection 50mg; 100mg RIBAVIRIN Tablet 200mg
For Chronic Hepatitis ‘C’ Use in accordance with NICE (TA200)
5.4 Antiprotozoal drugs 5.4.1 Antimalarials CHLOROQUINE Tablet 250mg (=155mg PHOSPHATE (AVLOCHLOR®) CHLOROQUINE Syrup 68mg (= 50mg SULPHATE Tablet 200mg (= 150mg MEFLOQUINE Tablet 250mg PRIMAQUINE Tablet 7.5mg
Treatment of Malaria For Genito Urinary Medicine Unlicensed Medicine
PROGUANIL Tablet 100mg PROGUANIL Tablet 100mg/250mg HYDROCHLORIDE with atovaquone (MALARONE®) PYRIMETHAMINE Tablet 25mg PYRIMETHAMINE Tablet 25mg/500mg with sulfadoxine (FANSIDAR®) QUININE Injection 300mg in 1ml, DIHYDROCHLORIDE 5.4.8 Drugs for pneumocystis pneumonia PENTAMIDINE Injection 300mg
Unlicensed Medicine For Genito Urinary Medicine
ISETIONATE
Stiff-Person Syndrome Following West Nile Fever Sharon Hassin-Baer, MD; Eilon D. Kirson, MD, PhD; Lester Shulman, PhD; Aron S. Buchman, MD; Hanna Bin, PhD;Musa Hindiyeh, PhD; Lea Markevich; Ella Mendelson, PhD Background: Stiff-person syndrome is a rare autoim- Result: The search revealed a stretch of 12 amino acids mune disorder associated with antibodies against glu-in the NS1 protei
Literaturverzeichnis Prevalence, Demographics and Risk Factors for Colic. AAEP Proceedings, Focus Equine Colic, Québec City, Canada http://www.pferd-aktuel .de/Wir-ueber-uns/Zahlen-Fakten 3. Tinker MK, White NA, Lessard P, Thatcher CD, Pelzer KD, Davis B, Carmel DK (1997): Prospective study of equine colic risk factors. Risk factors associated with development of diarrhea in horses after